Quarter

Zacks Small Cap Research – CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Update on the DrugSorb-ATR Regulatory Process Management reiterated that their De Novo DrugSorb-ATR submission continued to be in interactive review with FDA, that their Medical Device License application to Health Canada was in advanced review, and that they continue to expect regulatory decisions in … Read more

Zacks Small Cap Research – MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results – Go Health Pro

by
Zacks Small Cap Research – MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results – Go Health Pro

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th quarter and full year 2024 financial results on March 12th which were largely in line with our expectations. Research and development expenses for 2024 were $8.8 million compared to $10.6 million in … Read more

Zacks Small Cap Research – UHAL: Reports 3Q FY2025 Results: Demand for self-moving equipment rentals increases YOY for the 3rd consecutive quarter after seven quarters of single-digit declines. Self-Storage continues to deliver top-line growth. Record amount of self-storage rentable sq. ft. added in last 12 months. – Go Health Pro

by
Zacks Small Cap Research – UHAL: Reports 3Q FY2025 Results: Demand for self-moving equipment rentals increases YOY for the 3rd consecutive quarter after seven quarters of single-digit declines. Self-Storage continues to deliver top-line growth. Record amount of self-storage rentable sq. ft. added in last 12 months. – Go Health Pro

By Steven Ralston, CFA NYSE:UHAL READ THE FULL UHAL RESEARCH REPORT U-Haul Holding Company (NYSE:UHAL) reported financial results for 3Q FY2025 on February 5th. Total revenues increased 3.7% to approximately $1.39 billion, primarily due to stronger revenue growth of 4.6% in the self-moving equipment rental business, along with a 7.9% increase in theself-storage segment. In … Read more

Zacks Small Cap Research – LOBO: Busy Quarter on the Product/Distribution/Capital Fronts; Earnings Power Set to Ramp Up – Go Health Pro

by

By Michael Kim NASDAQ:LOBO LOBO EV Technologies (NASDAQ:LOBO) designs and manufactures e-Bicycles, e-Mopeds, motorcycles, e-Tricycles, autonomous robotic lawn mowers, and electric off-highway four-wheeled shuttles (golf carts and scooters for elderly and disabled persons) for distribution through a broad-based dealership network in China, Southeast Asia, Latin America, Europe, and the United States. Following the release of … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more